Iole anti-SARS-COV-2 NP monoclonal antibody

Hoʻolauna

PurificationProtein A/G affinity columnIsotypeIgG1 kappaHost SpeciesMouseSpecies ReactivityHumanApplicationImmunochromatography (IC)/Chemiluminescent Immunoassay (CLIA)

Nā kikoʻī huahana

Huahana Huahana

Nā kikoʻī huahana

ʻIke Nui
ʻO SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2), i ʻike ʻia ʻo 2019-nCoV (2019 Novel Coronavirus) kahi maʻi RNA i hoʻopaʻa ʻia hoʻokahi no ka ʻohana coronaviruses.ʻO ia ka hiku o ka coronavirus i ʻike ʻia e hoʻopilikia i ka poʻe ma hope o 229E, NL63, OC43, HKU1, MERS-CoV, a me ka SARS-CoV kumu.

Waiwai

Manaʻo Pair CLIA (Hopu-Hopu):9-1 ~ 81-4
Maemae >95% e like me ka mea i hoʻoholo ʻia e SDS-PAGE.
Hoʻohāpai ʻia PBS, pH7.4.
Waihona E mālama iā ia ma lalo o nā kūlana sterile ma -20 ℃ a -80 ℃ ma ka loaʻa ʻana.No ka mālama lōʻihi, e ʻoluʻolu e aliquot a mālama.E hōʻalo i nā pōʻai maloʻo a hoʻolulu.

ʻIke Kauoha

inoa mea kūʻai Cat.ʻAʻole Klone ID
SARS-COV-2 NP AB0046-1 9-1
AB0046-2 81-4
AB0046-3 67-5
AB0046-4 54-7

'Ōlelo Aʻo: hiki ke hoʻololi i ka nui o kāu pono.

Nānā Hoʻohālikelike

Kuhikuhi

1. Pūʻulu Haʻawina ʻo Coronaviridae o ke Kōmike International no ka ʻauhau o nā maʻi maʻi.ʻO ka coronavirus pili i ka maʻi respiratory acute respiratory syndrome: hoʻokaʻawale i ka 2019-nCoV a kapa ʻia ʻo SARS-CoV-2.Nat.Microbiol.5, 536–544 (2020)
2.Fehr, AR & Perlman, S. Coronaviruses: he hiʻohiʻona o kā lākou replication a me pathogenesis.Nā ʻano hana.Mol.Biola.1282, 1–23 (2015).
3.Shang, J. et al.ʻO ke kumu kumu o ka ʻike ʻana i ka mea hoʻokipa e SARS-CoV-2.Nature https://doi.org/10.1038/ s41586-020-2179-y (2020).


  • Mua:
  • Aʻe:

  • E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou

    ʻenehana loea loea i hoʻolaʻa ʻia e alakaʻi iā ʻoe

    E like me kāu mau pono maoli, e koho i nā kaʻina hana hoʻolālā holoʻokoʻa kūpono loa